Skip to main content
Skip to navigation

Fresenius Medical Discloses FCPA Probe

By Jaclyn Jaeger2014-05-07T15:30:00

lock icon THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.

Become a Member

News and analysis for the well-informed compliance or audit exec. Select an option and click continue.

Annual Membership $499 Value offer

Full price one year membership with auto-renewal.

Membership $599

One-year only, no auto-renewal.

Access CW Newsletters and CPE webcasts. REGISTER FOR LIMITED FREE ACCESS

Already a Compliance Week member?

Related articles

Blog
Fresenius Medical Care reaches ‘agreement in principle’ in FCPA case

2019-02-27T09:30:00Z By Jaclyn Jaeger

German healthcare company Fresenius Medical Care has reached an “agreement in principle” with U.S. authorities concerning an investigation into possible violations of the Foreign Corrupt Practices Act, booking charges of €224 million (U.S. $255 million) as of Dec. 31, 2018.
Blog
Fresenius Medical Care reserves €200 million in FCPA case

2018-02-27T11:45:00Z By Jaclyn Jaeger

Germany-based Fresenius Medical Care, a provider of dialysis products and services, has set aside €200 million concerning its ongoing settlement negotiations with the U.S. government regarding potential violations of the Foreign Corrupt Practices Act.